For these reasons, GH and IGF-1 could represent a novel strategy therapy in neurodegenerative diseases such as ALS, Alzheimer’s disease (AD), Parkinson, and dementia. The gene discussed is IGF1; the disease is early-onset autosomal dominant Alzheimer disease.